Save time and get answers to complex questions with AI chat
Brenzavvy discontinuation?Dabrafenib and trametinib cost?Atorvastatin side effects heart palpitations?Is januvia still on the market?Drugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for Ozempic
Ozempic is semaglutide, a long-acting GLP-1 receptor agonist. Structurally it is: - A 31‑amino‑acid peptide that is an analog of human GLP‑1. - It has a few key modifications to increase stability and half-life: - A substitution at position 8 with alpha‑aminoisobutyric acid (Aib) to resist DPP‑4 degradation. - A C18 fatty acid diacid chain attached via a linker to a lysine residue in the peptide (this fatty chain promotes strong albumin binding, extending the molecule’s half-life and enabling once‑weekly dosing). If you want a specific representation, I can provide: - A 2D structural diagram - The exact SMILES string - InChI/InChIKey - The amino acid sequence of semaglutide Tell me which format you prefer, and I can fetch or generate it. If you’d like a link to a database page with the structure, I can share that too.
Other Questions About Ozempic :